Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients

Journal of Pediatric Surgery

Volumn 43, Issue 6, 2008, Pages 1134-1141

  Sampson, Valerie B ^a   Dunn, Stephen P ^b   Rymeski, Beth ^a,c   Malatack, James ^b   Rong, Nancy H ^a   Flynn, Louise ^b   Krueger, Leslie J ^a  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

ATP; Child; Immune function; Infection; Rejection; Transplantation

Indexed keywords

ADENOSINE TRIPHOSPHATE; PHYTOHEMAGGLUTININ; RAPAMYCIN; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CHILD; DRUG BLOOD LEVEL; EPSTEIN BARR VIRUS; FEMALE; GRAFT RECIPIENT; GROUPS BY AGE; HUMAN; IMMUNE FUNCTION TEST; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INFECTION; INFRARED RADIATION; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LIVER GRAFT; LIVER GRAFT REJECTION; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; VIRUS LOAD;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOASSAY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; ORGAN TRANSPLANTATION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SIROLIMUS; T-LYMPHOCYTES; TACROLIMUS; TRANSPLANTATION IMMUNOLOGY;

EID: 44949252171     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2008.02.044     Document Type: Article

References (14)

1. Bucuvalas J.C., Ryckman F.C., Arya G., et al. A novel approach to managing variation: outpatient therapeutic monitoring of calcineurin inhibitor blood levels in liver transplant recipients. J Pediatr 146 (2005) 744-750
2. Dunn S.P. Statistical process control and calcineurin inhibitor management. J Pediatr 146 (2005) 720-721
3. D'Antiga L., Del R.M., Mengoli C., et al. Sustained Epstein-Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD. Liver Transplant 13 (2007) 343-348
4. Robinson L.G., Hilinski J., Graham F., et al. Predictors of cytomegalovirus disease among pediatric transplant recipients within one year of renal transplantation. Pediatr Transplant 6 (2002) 111-118
5. Haddad E.M., McAlister V.C., Renouf E., et al. Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev 4 (2006) CD005161
6. Rovira P., Mascarell L., and Truffa-Bachi P.M. The impact of immunosuppressive drugs on the analysis of T cell activation. Curr Med Chem 7 (2000) 673-692
7. Kowalski R., Post D., Schneider M.C., et al. Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant 17 (2003) 77-88
8. Zeevi A., Britz J.A., Bentlejewski C.A., et al. Monitoring immune function during tacrolimus tapering in small bowel transplant recipients. Transpl Immunol 15 (2005) 17-24
9. Hooper E., Hawkins D.M., Kowalski R.J., et al. Establishing pediatric immune response zones using the Cylex ImmuKnow assay. Clin Transplant 19 (2005) 834-839
10. Perkins R.S., Sahm K., Marando C., et al. Analysis of Epstein-Barr virus reservoirs in paired blood and breast cancer primary biopsy specimens by real time PCR. Breast Cancer Res 8 (2006) R70
11. Spencer C.M., Goa K.L., and Gillis J.C. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation. Drugs 54 (1997) 925-975
12. Ahmed M., Venkataraman R., Logar A.J., et al. Quantitation of immunosuppression by tacrolimus using flow cytometric analysis of interleukin-2 and interferon-gamma inhibition in CD8(-) and CD8(+) peripheral blood T cells. Ther Drug Monit 23 (2001) 354-362
13. Lee T.C., Goss J.A., Rooney C.M., et al. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection. Clin Transplant 20 (2006) 689-694
14. Kowalskii R.J., Post D.R., Mannon R.B., et al. Assessing relative risks of infection and rejection: a meta-analysis using an immune function test. Transplantation 3 (2006) 196-197